# Study of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate

> **NCT00647920** · PHASE3 · COMPLETED · sponsor: **Abbott** · enrollment: 47 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **BIOLOGICAL:** adalimumab
- **BIOLOGICAL:** placebo

## Key facts

- **NCT ID:** NCT00647920
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** 2005-04
- **Final completion:** —
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2008-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00647920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00647920, "Study of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00647920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*